MTOR and acute myeloid leukemia: In the present study we show that inhibitors of the PI3K and mTOR pathway may affect leukemogenesis through inhibition of the constitutive release of angioregulatory mediators both when investigating primary AML cells derived from a large group of unselected patients [29] as well as bone marrow stromal cells [23, 24].